Archive for the ‘Crohn’s Disease’ Category

The right diet for Crohn’s disease

Monday, October 10th, 2011

Crohn’s disease, a form of irritable bowel syndrome, can be a difficult condition to cope with. However, eating well and being educated about a proper diet for Crohn’s can help patients improve nutrient absorption and encourage a better digestive flow.

It is important to understand that there is no food that actually causes Crohn’s, but that watching what you eat can drastically improve your symptoms.

According to CNN, eating five small meals per day (one every three or four hours) on a regular basis will help decrease abdominal discomfort. During flare-ups, the source recommends that patients avoid high-fiber, greasy and fried foods. Additionally, alcohol and dairy products are likely to contribute to cramping and diarrhea.

Considering that Crohn’s disease is a condition of the bowels, the most obvious dietary change may be to switch to a low-fiber diet – up to 15 grams per day. These foods are easier to digest, which is helpful to those whose small intestines have narrowed or become constricted. Fruits and vegetables, as well as white bread and various meats are the best options.

Another way to maintain regularity is to drink enough fluids throughout the day to avoid dehydration, particularly when suffering from chronic diarrhea. CNN suggests drinking “one-half ounce for every pound of body weight each day. So if you weigh 140 pounds, try to drink at least 70 ounces per day.”

Lastly, if your IBS is causing malnutrition, you may want to pick up some dietary supplements to get important vitamins and minerals, such as B-12 and D.

Most common user conditions: Crohn’s disease

Tuesday, August 16th, 2011

Crohn’s disease is a form of inflammatory bowel disease (IBD), which affects approximately 1 million Americans. Half reportedly suffer from Crohn’s, while the other half have another form of IBD known as ulcerative colitis.

More than 250 Healthetreatment members have reported their experiences with Crohn’s, with 81 percent of respondents being female. According to the American Journal of Gastroenterology, gender does play a part in the development of this disease; however, it has been found that age is a risk factor as well. There is currently no known cause for Crohn’s.

Approximately 80 percent of members have experienced severe abdominal discomfort, which is one of the defining characteristics of Crohn’s. Inflammation often spreads to other areas of the body and many users have also suffered from appetite loss, bloating, fatigue, bleeding, diarrhea and other symptoms. Patients may experience weight loss as well.

Sufferers are often prescribed anti-inflammatory drugs, immunosuppressants, corticosteroids and antibiotics, although it is not uncommon for a doctor to recommend a surgical procedure. Most of Healthetreatment’s users who are living with Crohn’s disease take Prednisone for relief, giving it a 4/5 rating for effectiveness. Other treatments reported by our members include Imuran, mesalazine, Remicade and Imodium.

For more information on Crohn’s disease and to read about the experiences of more than 100 other patients like you, click here.

Crohn’s disease patients show improvement with psoriasis drug

Friday, May 27th, 2011

Those suffering from Crohn’s Disease may have a new option when it comes to treatments, as research has revealed the drug Stelara to be beneficial to patients with this condition, according to DrugWatch.

Stelara is indicated for the treatment of plaque psoriasis. However, patients with moderate to severe forms of the Crohn’s disease showed a decrease in symptoms when using the drug.

The six-week study found that 40 percent of those treated with Stelara showed a positive clinical response, and 70 percent of these patients continued seeing improvements beyond the initial length of the research project.

“To see these kind of outcomes, where you have high response rates in the short term and then good remission rates out toward five or six months of therapy, it shows unequivocally that the drug is effective for treating Crohn’s disease,” Dr. William Sandborn, who led the study, told the news source.

The significant portion of people whose symptoms greatly improved also reported a better quality of life. Researchers took into account their frequency of soft stools and abdominal pain, weight changes, usage with other medications and other factors.

While Stelara is not yet FDA-approved for treating Crohn’s disease, it still showed a higher success rate over medications like Humira, Enbrel and Remicade.